The multidisciplinary research team reported their findings in JAMA
Research helps identify patients who might benefit from adjuvant therapies
Work will pair predictive modeling and genomic expertise with COVID-19 registry and biobank
Risk model is second in a suite of prediction tools for infected patients
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Nomogram reveals new characteristics that may affect risk
Tools to aid in diagnosis, complication management and lifestyle interventions